Alprostadil/SEPA - MacroChem

Drug Profile

Alprostadil/SEPA - MacroChem

Alternative Names: Prostaglandin E1/SEPA - MacroChem; Topiglan

Latest Information Update: 29 Jun 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MacroChem
  • Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Erectile dysfunction

Most Recent Events

  • 23 Jun 2004 Discontinued - Phase-II for Erectile dysfunction in United Kingdom (Topical)
  • 23 Jun 2004 Discontinued - Phase-II for Erectile dysfunction in USA (Topical)
  • 19 Apr 2004 Data from a media release have been added to the Mens Health therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top